Skip to content

IPS Mental Health & Employment Support Evaluation

Examining the effect of Individual Placement and Support for those receiving mental health support on employment and health outcomes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN71067067
Enrollment
6550
Registered
2015-08-13
Start date
2016-07-31
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health Mental and Behavioural Disorders

Interventions

1. The control condition will receive mental health treatment as usual e.g. Improving Access to Psychological Therapies (IAPT), medication, GP support. 2. The treatment group will receive mental heal

Sponsors

HM Cabinet Office
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participants will be required to be in receipt of unemployment benefits. 2. Participants will be required to score within the mild to severe categorisation of the Patient Health Questionnaire 9 and the Generalized Anxiety Disorder 7.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will involve whether the individuals are off unemployment benefits at 3 and 6 months after entering the intervention. This will be collected via Department for Work and Pensions administrative data.

Secondary

MeasureTime frame
Secondary outcome measures will include sub sample analysis (e.g. those who are long-term unemployed, those with higher levels of mental health difficulties, gender effects). In addition, for a sub sample of participants we will use mental health as an outcome measure (using PHQ9 and GAD7). We will also include administrative data from HSCIC to measure proxy health outcomes (e.g. hospital admissions, prescriptions). For data collected administratively (i.e. demographics data and HSCIC data), these will be collected 3 and 6 months after entry into the trial.

Countries

United Kingdom

Contacts

Public ContactAisling Ní Chonaire

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026